Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.

Abstract excerpt

Waldenström macroglobulinemia (WM) is a chronic B-cell lymphoproliferative disorder characterized by lymphoplasmacytic cell overgrowth in the bone marrow and increased secretion of IgM immunoglobulins into the serum. Patients with WM have a variety of clinical outcomes, including long-term survival but inevitable recurrence. Recent advances in disease knowledge, including molecular and genetic principles with the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Myeloid Differentiation Factor 88